The Journal of Allergy and Clinical Immunology
Volume 119, Issue 4 , Pages 930-936, April 2007

Staphylococcus aureus sensitization and allergic disease in early childhood: Population-based birth cohort study

  • Aida Semic-Jusufagic, MD

      Affiliations

    • From the University of Manchester
    • Corresponding Author InformationReprint requests: Aida Semic-Jusufagic, MD, University of Manchester, North West Lung Centre, Wythenshawe Hospital, Manchester M23 9LT, United Kingdom.
  • ,
  • Claus Bachert, MD, PhD

      Affiliations

    • University of Ghent
  • ,
  • Philippe Gevaert, MD

      Affiliations

    • University of Ghent
  • ,
  • Gabriele Holtappels, BSc

      Affiliations

    • University of Ghent
  • ,
  • Lesley Lowe, PhD

      Affiliations

    • From the University of Manchester
  • ,
  • Ashley Woodcock, MD, FRCP

      Affiliations

    • From the University of Manchester
  • ,
  • Angela Simpson, MD, MRCP

      Affiliations

    • From the University of Manchester
  • ,
  • Adnan Custovic, MD, PhD

      Affiliations

    • From the University of Manchester

Received 26 September 2006; received in revised form 12 December 2006; accepted 14 December 2006. published online 14 February 2007.

Manchester, United Kingdom, and Ghent, Belgium

Background

Staphylococcus aureus–secreted enterotoxins (SEs) may be involved in the pathophysiology of atopic diseases.

Objective

We investigated the role of SEs in allergic diseases during early childhood (using the mixture of SE-specific IgEs [SE-mix] as a marker).

Methods

Children (N = 510) were followed from birth to age 5 years (repeated questionnaires, IgE to inhalant and food allergens, lung function [spirometry, plethysmography], airway reactivity [dry air challenge]). We measured SE-mix specific IgE (SE-A, SE-C, toxic shock syndrome toxin 1) by using fluorescence immunoassay.

Results

We found no association between rhinitis and SE-mix sensitization. Children with eczema were more frequently SE-mix–sensitized than children without (17.4% vs 8.3%; P = .02). SE-mix sensitization rate increased significantly with increasing eczema severity (no eczema, mild, moderate/severe: 8.3%, 14.8%, 42.9%; P = .003) and remained independently associated with eczema in a multivariate model adjusting for total IgE (adjusted odds ratio, 2.19; 95% CI, 1.05-4.56; P = .04). SE-mix sensitization was associated with current wheeze in the univariate but not the multivariate model. Among wheeze phenotypes, persistent wheezers were most commonly sensitized to SE-mix (never, transient, late-onset, persistent: 8.5%, 3.8%, 7.7%, 17.6%; P = .05). Among wheezers, those SE-mix–sensitized had significantly higher airway reactivity compared with those nonsensitized (mean FEV1 change, mL [95% CI]: −59 [−121, 3] vs 19 [−10.2, 48.9]; P = .04), with little difference after adjusting for atopy.

Conclusion

We found differences in SE-mix IgE antibodies between healthy 5-year-old children and children with eczema and wheeze. The proportion of patients sensitized to SE-mix increases with increasing disease severity.

Clinical implications

Staphylococcal enterotoxins are potential modifiers of childhood wheeze and eczema.

Key words: Staphylococcus aureus, superantigens, early life, wheeze, eczema

Abbreviations used: MAAS, Manchester Asthma and Allergy Study, SE, Staphylococcus aureus–secreted enterotoxin, SE-mix, Mixture of SE-specific IgEs, sRaw, Specific airway resistance, TSST-1, Toxic shock syndrome toxin 1

 

 Supported by Asthma UK grant #04/014 and a grant from the Flemish Scientific Research Board, Fonds voor Wetenschappelijk Onderzoek, Nr A12/5-K/V-K17.Disclosure of potential conflict of interest: All of the authors have received grant support from Asthma UK and the Flemish Scientific Research Board.

PII: S0091-6749(06)03908-X

doi:10.1016/j.jaci.2006.12.639

The Journal of Allergy and Clinical Immunology
Volume 119, Issue 4 , Pages 930-936, April 2007